STAT4 deficiency exacerbates foam cell formation and atherosclerosis via MiR-9-dependent pathway in ApoE-/-mice
Author:
Affiliation:

Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China)

Clc Number:

R541.4

  • Article
  • | |
  • Metrics
  • |
  • Reference [41]
  • | | | |
  • Comments
    Abstract:

    Aim The aim of the present study is to determine the function of signal transducer and activator of transcription 4 (STAT4) signal in macrophage differentiationand foam cell formation during the development of atherosclerosis. Methods STAT4 knockout (STAT4-/-) mice were crossed with Apolipoprotein E knockout mice (ApoE-/-)to establish a novel atherosclerosis related mice model- APOE/STAT4 double knockout (DKO) mice. WT,STAT4-/-,ApoE-/- and DKOmice (3-month-old adult mice) were challenged with high-fat diet for 12 weeks. The extent of atherosclerosis was determined by oil-red staining and HE staining. Changes in subsets of immune cells were evaluated by flow cytometry. Macrophage differentiation was induced from the CD11b+ myeloid cells directly isolated from the bone marrow of transgenic mice with macrophage colony stimulating factor (M-CSF) incubation. Realtime polymerase chain reaction (RT-PCR) and Westernblot were applied to detect the expression levels of related genes and protein. Results The expression of STAT4 was identified in CD11b+ myeloid cells in atherosclerotic plaque. Genetic deletion of STAT4 significantly exacerbated atherosclerosis in ApoE-/- mice as evidenced by significant increases of oilred O-positive lipid-rich lesion, vascular inflammation, and necrotic core lesion in atherosclerotic plaques of DKO mice compared to ApoE-/-mice. The accelerated atherosclerotic process is associated with abnormal mobilization and differentiation of macrophages from CD11b+Gr-1+ immature myeloid cells and with the enhanced formation of macrophages-derived foam cells in DKO mice. Furthermore,the mechanism studies revealed that the disruption of STAT4 signal leads to the inhibition of phosphatidylinositol-3 kinase(PI3K)/serine-threonine kinases (Akt)/nuclear factor kappa B (NF-κB)/miR-9 signaling pathway and consequently up-regulates the expression of acyl coenzyme A:cholesterol acyltransferase-1 (ACAT-1), an enzyme that esterifies cholesterol and promotes its storage in macrophages and foam cells. Conclusion The results suggest that the STAT4 signal plays important roles in both immune responses and cholesterol metabolism during the differentiation of macrophages. Targeting STAT4 related signals may develop a novel pharmacotherapeutic target for the treatment of atherosclerotic diseases.

    Reference
    [1] Hansson GK.Inflammation, atherosclerosis, and coronary artery disease.N Engl J Med, 5,2(16):1685-1695.
    [2] Paoletti R, Gotto AJ, Hajjar DP.Inflammation in atherosclerosis and implications for therapy.Circulation, 4,9(23 Suppl 1):I20-I26.
    [3] Zeller I, Srivastava S.Macrophage functions in atherosclerosis.Circ Res, 4,5(12):e83-e85.
    [4] Koelwyn GJ, Corr EM, Erbay E, et al.Regulation of macrophage immunometabolism in atherosclerosis.Nat Immunol, 8,9(6):526-537.
    [5] Moore KJ, Koplev S, Fisher EA, et al.Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis:JACC Macrophage in CVD Series (Part 2).J Am Coll Cardiol, 8,2(18):2181-2197.
    [6] Mills CD, Ley K.M1 and M2 macrophages:the chicken and the egg of immunity.J Innate Immun, 4,6(6):716-726.
    [7] 白瑞娜, 郗瑞席, 冯志博, 等.巨噬细胞与动脉粥样硬化——亚型及功能.中国循环杂志, 4,9(5):393-395.
    [8] Koltsova EK, Hedrick CC, Ley K.Myeloid cells in atherosclerosis:a delicate balance of anti-inflammatory and proinflammatory mechanisms.Curr Opin Lipidol, 3,4(5):371-380.
    [9] Youn JI, Nagaraj S, Collazo M, et al.Subsets of myeloid-derived suppressor cells in tumor-bearing mice.J Immunol, 8,1(8):5791-5802.
    [10] Chistiakov DA, Kashirskikh DA, Khotina VA, et al.Immune-inflammatory responses in atherosclerosis:the role of myeloid cells.J Clin Med, 9,8(11):1-12.
    [11] Chen J, Hong T, Ding S, et al.Aggravated myocardial infarction-induced cardiac remodeling and heart failure in histamine-deficient mice.Sci Rep, 7,7:44007.
    [12] Jutel M, Watanabe T, Klunker S, et al.Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors.Nature, 1,3(6854):420-425.
    [13] Obara I, Telezhkin V, Alrashdi I, et al.Histamine, histamine receptors, and neuropathic pain relief.Br J Pharmacol, 0,7:580-599.
    [14] Xu L, Cheng D, Huang Z, et al.Histamine promotes the differentiation of macrophages from CD11b+ myeloid cells and formation of foam cells through a Stat6-dependent pathway.Atherosclerosis, 7,3:42-52.
    [15] Wang KY, Tanimoto A, Guo X, et al.Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level.Arterioscler Thromb Vasc Biol, 1,1(4):800-807.
    [16] Wurster AL, Tanaka T, Grusby MJ.The biology of Stat4 and Stat6.Oncogene, 0,9(21):2577-2584.
    [17] Yokota N, Burne-taney M, Racusen L, et al.Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury.Am J Physiol Renal Physiol, 3,5(2):F319-F325.
    [18] Bell FP, Gammill RB, St JL.U-73482:a novel ACAT inhibitor that elevates HDL-cholesterol, lowers plasma triglyceride and facilitates hepatic cholesterol mobilization in the rat.Atherosclerosis, 2,2(2-3):115-122.
    [19] Terasaka N, Miyazaki A, Kasanuki N, et al.ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice.Atherosclerosis, 7,0(2):239-247.
    [20] Matsuo K, Akakabe Y, Kitamura Y, et al.Loss of apoptosis regulator through modulating IAP expression (ARIA) protects blood vessels from atherosclerosis.J Biol Chem, 5,0(6):3784-3792.
    [21] Wang D, Yang Y, Lei Y, et al.Targeting foam cell formation in atherosclerosis:therapeutic potential of natural products.Pharmacol Rev, 9,1(4):596-670.
    [22] Chistiakov DA, Melnichenko AA, Myasoedova VA, et al.Mechanisms of foam cell formation in atherosclerosis.J Mol Med (Berl), 7,5(11):1153-1165.
    [23] Miyazaki A, Sakashita N, Lee O, et al.Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages.Arterioscler Thromb Vasc Biol, 8,8(10):1568-1574.
    [24] Bartel DP.MicroRNAs:genomics, biogenesis, mechanism, and function.Cell, 4,6(2):281-297.
    [25] Dong H, Lei J, Ding L, et al.MicroRNA:function, detection, and bioanalysis.Chem Rev, 3,3(8):6207-6233.
    [26] Najafi-shoushtari SH, Kristo F, Li Y, et al.MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.Science, 0,8(5985):1566-1569.
    [27] Rotllan N, Fernandez-hernando C.MicroRNA regulation of cholesterol metabolism.Cholesterol, 2,2:847-849.
    [28] Van RE, Olson EN.MicroRNA therapeutics for cardiovascular disease:opportunities and obstacles.Nat Rev Drug Discov, 2,1(11):860-872.
    [29] Xu J, Hu G, Lu M, et al.MiR-9 reduces human acyl-coenzyme A:cholesterol acyltransferase-1 to decreas楥渠湔慈瑐攭?椠浭浡畣湲敯?牨敡獧灥漭湤獥敲獩?健牤漠捦?乡慭琠汣??捬愠摦?卲捭楡?啩卯????????????????????????扩牮????扡牮?hai), 3,5(11):953-962.
    [30] Li W, Wang H, Kuang CY, et al.An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro.Mol Cell Biochem, 2,3(1-2):135-145.
    [31] Geissmann F, Manz MG, Jung S, et al.Development of monocytes, macrophages, and dendritic cells.Science, 0,7(5966):656-661.
    [32] Tabas I, Lichtman AH.Monocyte-macrophages and T cells in atherosclerosis.Immunity, 7,7(4):621-634.
    [33] Mantovani A, Biswas SK, Galdiero MR, et al.Macrophage plasticity and polarization in tissue repair and remodelling.J Pathol, 3,9(2):176-185.
    [34] Moore KJ, Tabas I.Macrophages in the pathogenesis of atherosclerosis.Cell, 1,5(3):341-355.
    [35] 谭艳美, 孟磊, 汪江波, 等.巨噬细胞极化与动脉粥样硬化.中国动脉硬化杂志, 6,4(2):207-212.
    [36] Szabo SJ, Dighe AS, Gubler U, et al.Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells.J Exp Med, 7,5(5):817-824.
    [37] Varikuti S, Oghumu S, Natarajan G, et al.STAT4 is required for the generation of Th1 and Th2, but not Th17 immune responses during monophosphoryl lipid A adjuvant activity.Int Immunol, 8,0(8):385.
    [38] Chen T, Huang Z, Wang L, et al.MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages.Cardiovasc Res, 9,3(1):131-139.
    [39] Forrest AR, Kanamori-katayama M, Tomaru Y, et al.Induction of microRNAs, miR-155, miR-222, miR-424 and miR-503, promotes monocytic differentiation through combinatorial regulation.Leukemia, 0,4(2):460-466.
    [40] Li B, Cheung PY, Wang X, et al.Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells.Carcinogenesis, 7,8(11):2313-2320.
    [41] Taganov KD, Boldin MP, Chang KJ, et al.NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

XU Lili, DING Suling, ZHANG Weiwei, ZHU Xiaowei, ZHU Baoling, ZOU Yunzeng, YANG Xiangdong, GE Junbo. STAT4 deficiency exacerbates foam cell formation and atherosclerosis via MiR-9-dependent pathway in ApoE-/-mice[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(5):410-420.

Copy
Share
Article Metrics
  • Abstract:659
  • PDF: 832
  • HTML: 0
  • Cited by: 0
History
  • Received:February 04,2020
  • Revised:February 26,2020
  • Online: May 26,2020
Article QR Code